News

Phacoemulsification technology has advanced steadily in the past decade, and the major phaco platforms available in the United States all are refined, highly efficacious systems.

The dilemma of selling multiple pairs of eyewear to our patients is that we may actually be sabotaging this effort ourselves.

Experience using a proprietary femtosecond laser with an integrated, real-time optical coherence tomography imaging device highlights the advantages provided by this technology in performing cataract surgery and its potential to raise the bar for functional and safety outcomes.

Over the past decade, prolific basic science and clinical research in all areas of vision care have led to multiple advances in clinical research.

Because of the versatility that 2.3% sodium hyaluronate provides, the author has used the ophthalmic viscosurgical device in every case for the past 5 years.

A combination ophthalmic viscosurgical device, 1.6% sodium hyaluronate, fills the bill during cataract surgery by combining the benefits of cohesive and dispersive agents in a single vial instead of two separate vials, making it more economical and simplifying surgery.

The author shares a favorite pasta dish and his reasons why he loves it.

ISTA Pharmaceuticals has initiated a phase I/II clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis.

The Melza M. and Frank Theodore Barr Foundation has given $1.6 million to the Glaucoma Research Foundation.

HOYA has formed a strategic partnership with Swiss company Adoptics through an investment that will fund the development of a shape-changing accommodating IOL.

William L. Rich III, MD, medical director of health policy for the American Academy of Ophthalmology, has been appointed to the National Quality Forum Efficiency Resource Use Project Steering Committee.

The Bascom Palmer Eye Institute at the University of Miami and the Wilmer Eye Institute at Johns Hospitals Hospital, Baltimore, have been named to the first and second spots, respectively, in the ophthalmology category of U.S. News and World Report?s 2010?2011 list of best hospitals for the seventh consecutive year.

The Magnum Group Inc. has been hired to solicit offers for the assets of NovaVision Inc., which filed for Chapter 7 bankruptcy in Florida April 28 after more than seven years of continuous operation.

Bausch + Lomb (B+L) is voluntarily recalling an eye vitamin (PreserVision Eye Vitamin AREDS 2 Formula with Omega 3) after receiving ?a small number of reports predominantly within a specific age group, age 70 and older, who reported difficulty swallowing or a choking sensation when taking the soft gel,? according to the company.

Alcon Laboratories is recalling a microsurgical system (Constellation Vision System) after identifying software and hardware issues associated with unexpected loss of power, unintended system error messages, unresponsive touch screens, and system setting and infusion performance problems.

The FDA has cleared a new C-loop, single-piece hydrophilic acrylic IOL (Softec ONE, Lenstec) for the treatment of patients with cataracts.

The FDA has granted approval for an abbreviated new drug application to market a generic version of azelastine ophthalmic solution 0.05% (Optivar, Meda Pharmaceuticals), according to Sun Pharmaceutical Industries.

EyeGate Pharma has begun enrolling patients in the ALLUVION (EvALuation of Dexamethasone Phosphate DeLivered by OcUlar Iontophoresis for the Treatment of Dry Eye in the Controlled Adverse EnVIrONment Model) pivotal phase III study of EGP-437 for the treatment of dry eye syndrome.

The National Eye Institute (NEI) has launched an ancillary study to the ongoing Age-Related Eye Disease Study 2, which has the aim of determining whether oral supplementation of lutein/zeaxanthin and omega-3 fatty acids can further slow the progression of vision loss from age-related macular degeneration.

A new silicone hydrogel daily disposable contact lens (1-Day Acuvue TruEye, Vistakon) is now available in the United States, after having been cleared by the FDA in June.

Ophthalmic Women Leaders and Women In Ophthalmology announce a joint partnership in presenting the WIO Summer Symposium, Aug. 12 to 15, at the Pinehurst Resort in Pinehurst, NC.

Pediatric eye surgeon Arthur L. Rosenbaum, MD, died June 22 at the Ronald Reagan UCLA Medical Center after a long illness due to complications from cancer.

Lux Biosciences Inc. announced the appointment of Dean Mitchell as president and chief executive officer.

Nicholas J. Volpe, MD, professor and holder of the Adele Niessen Chair in Ophthalmology at the University of Pennsylvania School of Medicine, has been named the new chairman of ophthalmology at Northwestern Medicine, effective Sept 1.

Bausch + Lomb has named Robert E. Grant chief executive officer and president of its global surgical business, effective Aug. 1.

Alimera Sciences has submitted a new drug application to the FDA for its investigational sustained drug delivery system releasing sub-microgram levels of fluocinolone acetonide (Iluvien) for the treatment of diabetic macular edema.

VisionCare Ophthalmic Technologies Inc. announced the FDA approval of the company?s Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to improve vision in patients with end-stage age-related macular degeneration.

The FDA has approved ranibizumab injection (Lucentis, Genentech) for the treatment of macular edema following retinal vein occlusion after a 6-month priority review.

Alcon Laboratories announced that it has entered into a definitive agreement to acquire LenSx Lasers Inc., a privately held company located in Aliso Viejo, CA, that developed the first femtosecond laser to receive FDA clearance for use as a part of cataract surgery.

After 4 years of follow-up in a clinical trial, the angle-supported foldable acrylic phakic IOL is continuing to provide patients treated for moderate to high myopia with good visual acuity thanks to accurate predictability, a stable refractive outcome, and good safety.